Loading...

RNXT RENOVORX INC Earnings Reports 8-K Filing

RNVR

RNXT

RENOVORX INC

(RNXT)

2026 8-K

Financial Results Report

Financial Update

Leadership Change

Stock Offering Details

Management Changes

Nasdaq Deficiency Notice

Sales Agreement Established

Financial Results Update

Financial Results Update

Financial Statements

Financial Results

Financial Results

Production Increase

Accountant Change

Departure of Directors and ...

Compliance with Nasdaq List...

Private Placement Offering

Private Placement Offering

Appointment of Chief Clinic...

Management Changes

Private Placement Offering

Passing of David Diamond

Submission of Matters to a ...

Earnings Reports

Listing Compliance Extension

Financial Results Announcement

Announcement of Positive In...

Annual Meeting of Stockholders

Financial Results Announcement

Appointment of Director

Securities Purchase Agreeme...

Financial Results and Clini...

External Links:

On March 30, 2026, RenovoRx, Inc. announced its financial results for the year ending December 31, 2025, along with updates on its clinical trial and commercialization strategy. This filing is significant as it provides crucial insight into the company's performance and future direction.

AI Assistant

RENOVORX INC

2026

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.